Gilead Sciences, Inc. recalls Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxi
Recalled Product
Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1
Hazard / Issue
Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: TRUVADA (NDA 21-752; NDC 61958-0701-1) Lot# 002808, Expiration Date: 31 December 2017
View official government recall
Were you affected by this recall?
If you were harmed by a recalled product, you may have legal options. Consider speaking with a consumer protection lawyer in your state.
Looking for safe alternatives?
Browse certified-safe products in this category on Amazon →
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime